A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China

Clinical trial NCT07450170 · COMPLETED

Trial details

NCT number: NCT07450170
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Urticaria

Start date: 2026-03-10
Primary completion: 2026-03-23
Enrollment: 3485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.